04/22/2024
3:10 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:04 AM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:22 PM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:17 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
10:21 AM | Intellia Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024
3:15 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:35 PM | BlackRock Inc. (Filed by)
Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/05/2024
3:44 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | BASTA JAMES (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:46 PM | Hicks Derek (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:49 PM | Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:50 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:50 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:51 PM | Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:28 PM | Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:30 PM | Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:34 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:35 PM | Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:09 PM | Crowley John F (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
8:30 AM | Intellia Therapeutics (Filer)
| Form S-3ASR | |
11/09/2023
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:42 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
6:11 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
6:30 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
6:19 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:13 PM | Intellia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
4:19 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
3:45 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
4:21 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:22 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/06/2023
2:34 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:52 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:39 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:24 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
06/16/2023
3:26 PM | Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:13 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
3:52 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:41 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
